News
Are you interested in learning about how to license from or collaborate with the NIH? Since the 1970s, the Intramural Research Program (IRP) has served as the in-house research and clinical arm of the NIH. Despite our success, many potential industry collaborators and licensees still see NIH solely
Inventors at the National Cancer Institute’s Laboratory of Molecular Biology have isolated three anti Programed Death-Ligand 1 (PD-L1) single domain antibodies that can be used as a therapeutic for treating solid tumors. An imbalance of PD-L1 contributes to cancer immune escape and it has been
Technology Transfer Central has selected Joseph M. Conrad, Ph.D. from the National Cancer Institute’s Invention Development and Marketing Unit (IDMU) to present a webinar focused on strategies to revitalize and expand a high-touch, low-tech approach to marketing technologies. This webinar will
NIH inventor Carolina Barillas-Mury, M.D., Ph.D., has been elected into the National Academy of Medicine (NAM) this year. The NAM is made up of over 2,000 elected members from around the globe who give scientific and policy guidance relating to human health. This honor is one of the highest that can